36 completed, 8 terminated, 4 unknown, 4 withdrawn. 13 Phase 2, 12 Phase 3, 10 Not applicable, 9 Phase 1, 9 Phase 4.
Follow Drugs, Generic: new trials by email Literature Review of Drugs, Generic trials Research Report on Drugs, Generic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SYS6043 Versus Investigator's Choice Chemotherapy as First-Line Treatment in Patients With Unresectable Locally Recurrent or Metastatic Triple-Negative Breast Cancer Enter a brief, descriptive name for the intervention. Use a non-proprietary (generic) name, if available. SYS6043, Investigator's Choice of Chemotherapy (paclitaxel，nab paclitaxel，capecitabine，eribulin，carboplatin） - Triple Negative Breast Cancer | Phase 3 | Not yet recruiting | CSPC Megalith Biopharmaceutical Co.,Ltd. | 550 | 2026-11-30 | 2026-10-19 |
| Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure Cyclophosphamide, Bortezomib (VELCADE), Dexamethasone - Myeloma Multiple | Phase 2 | Recruiting | Eastern Cooperative Oncology Group | 74 | 2026-03-05 | 2026-09-14 |
| Conventional Versus High-Voltage Long-Duration Pulsed Radiofrequency of the Pudendal Nerve Intervention Type * Select the type of intervention. Procedure / Surgery Intervention Name * Enter a brief, descriptive name for the intervention. Use a non-proprietary (generic) name, if available, High-Voltage Long-Duration Pulsed Radiofrequency - Pudendal Neuralgia | Not applicable | Recruiting | Ankara City Hospital Bilkent | 38 | 2025-02-19 | 2026-01-22 |
| Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC Omidria, {0.3%-1% Intraocular Solution}, VIGAMOX {0.5% moxifloxacin hydrochloride}, Kenalog {0.4 ml, 10mg/ml, triamcinolone acetonide}, Ketorolac (0.5%) {Toradol}, moxifloxacin (0.5%) {VIGAMOX}, prednisolone acetate (1%) {Pred Forte} - Cataract | Phase 1 / Phase 2 | Recruiting | Inder Paul Singh, M.D. | 94 | 2024-07-10 | 2024-11-29 |
| Consumer Responses to Alcohol Warnings Mouth cancer warning, Throat cancer warning, Voice box (larynx) warning - Alcohol Drinking | Not applicable | Completed | Stanford University | 2522 | 2024-01-18 | 2024-02-13 |
| A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205] THOR-707, Pembrolizumab - Classic Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma | Phase 2 | Terminated | Sanofi | 14 | 2021-12-07 | 2025-12-24 |
| A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) THOR-707, Pembrolizumab - Pleural Mesothelioma, Non-small Cell Lung Cancer | Phase 2 | Terminated | Sanofi | 106 | 2021-09-23 | 2025-10-02 |
| A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) THOR-707, Cemiplimab - Malignant Melanoma, Squamous Cell Carcinoma of Skin | Phase 1 / Phase 2 | Terminated | Sanofi | 46 | 2021-07-15 | 2026-02-04 |
| Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients Risedronate, Vitamin D - Postmenopausal Osteoporosis, Hypovitaminosis D | Not applicable | Completed | Hospital Regional 1o de Octubre | 33 | 2021-07-01 | 2022-04-26 |
| Vaginal Biorevitalization With Polydeoxyribonucleotides for the Improvement of the Genitourinary Syndrome of Menopause 3 g Polynucleotide vaginal suppositories, Conjugated estrogens cream 1g Tube - Genitourinary Syndrome of Menopause, Postmenopausal Disorder | Not applicable | Completed | Hospital Regional 1o de Octubre | 136 | 2021-06-23 | 2023-04-11 |
| Effect of Heat on Rivastigmine TDS Products Rivastigmine (RLD) transdermal patch, Rivastigmine (generic) transdermal patch - Bioavailability | Early Phase 1 | Completed | University of Maryland, Baltimore | 7 | 2019-10-04 | 2022-04-04 |
| A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI Intravenous N-Acetylcysteine - STEMI | Phase 2 | Completed | University of Alberta | 44 | 2019-09-20 | 2022-10-06 |
| A Pharmacovigilance Study of Brain Oedema Drugs, Generic - Brain Edema, Brain Edema Caused by Drugs | Completed | University of Peshawar | 9524 | 2019-05-20 | 2020-03-17 | |
| A Pharmacovigilance Study of Torsade de Pointes Drugs, Generic - Torsades de Pointe Caused by Drug | Completed | University of Peshawar | 6670 | 2019-05-15 | 2020-03-03 | |
| Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours Crizotinib Oral Capsule [Xalkori], Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic] - Lobular Breast Carcinoma, Gastric Cancer | Phase 2 | Completed | Royal Marsden NHS Foundation Trust | 33 | 2019-05-09 | 2025-10-30 |
| Doravirine, Rifapentine and Isoniazid Interaction Doravirine (DOR), Rifapentine (RPT), Isoniazid (INH) - Latent Tuberculosis, Human Immunodeficiency Virus | Phase 1 | Completed | Walter K. Kraft | 11 | 2019-04-22 | 2020-03-27 |
| Treatment of Nighttime Pruritus in Atopic Dermatitis Melatonin, Diphenhydramine, Placebos - Atopic Dermatitis | Early Phase 1 | Withdrawn | University of Nebraska | 2019-02-02 | 2024-09-03 | |
| A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations IR CD-LD, IPX203 ER CD-LD, Placebo Matching IPX203 - Parkinson's Disease (Disorder) | Phase 3 | Completed | Impax Laboratories, LLC | 630 | 2018-11-06 | 2023-02-09 |
| Post Implantation Syndrome and Administration on NSAIDs in Patients Undergoing EVAR for AAA Drugs, Generic (Naprosyn), Placebo Oral Tablet - Aneurysm Abdominal, Endovacular Repair | Not applicable | Unknown | University of Thessaly | 186 | 2018-08-01 | 2018-11-26 |
| Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate Pirfenidone (PFD), Placebo (Plac), Mycophenolate Mofetil (MMF) - Scleroderma, Systemic, Interstitial Lung Disease | Phase 2 | Completed | Michael Roth | 51 | 2017-11-28 | 2023-12-15 |
Showing 20 of 56. Sign in to see all of them.
Bone Diseases, Metabolic (2) · Diabetes Mellitus, Type 2 (2) · Pain (2) · Triple Negative Breast Neoplasms (2) · Acne Vulgaris (1) · Acquired Immunodeficiency Syndrome (1) · Alcohol Drinking (1) · Amyotrophic Lateral Sclerosis (1) · Angina, Stable (1) · Aortic Aneurysm, Abdominal (1) · Bone Resorption (1) · Brain Edema (1) · Breast Feeding (1) · Carcinoma, Lobular (1) · Carcinoma, Non-Small-Cell Lung (1)
University of Nebraska (4) · Sanofi (3) · Charles Drew University of Medicine and Science (2) · Hospital Regional 1o de Octubre (2) · University of Peshawar (2) · ARCAGY/ GINECO GROUP (1) · Actavis Inc. (1) · Ankara City Hospital Bilkent (1) · AstraZeneca (1) · CSPC Megalith Biopharmaceutical Co.,Ltd. (1) · Center for Weight Management, California (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Eastern Cooperative Oncology Group (1) · FixHepC (1) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1)
United States (28) · Spain (6) · France (5) · Italy (4) · Australia (3) · Chile (3) · United Kingdom (3) · Argentina (2) · Germany (2) · Mexico (2) · Pakistan (2) · Poland (2) · South Korea (2) · Brazil (1) · Canada (1)
Patricia Loranca-Moreno, M.D., M.Sc. (2) · Stanley Hsia, MD (2) · Alberto Albanese, MD (1) · Alison Edelman, MD (1) · Amany Keruakous (1) · Andre J Witkin, MD (1) · Anna Grummon, PhD (1) · Arthur J McCullough, MD (1) · Audra L Stinchcomb, PhD (1) · Biljana Lilja (1) · C M Stein, M.D. (1) · Craig J McClain, MD (1) · Ed J Hendricks, MD (1)
PMID 33166419, PMID 16940094, PMID 18394706, PMID 18477269, PMID 20455694, PMID 20643821, PMID 20701619, PMID 21146881, PMID 21248083, PMID 23275364, PMID 24022862, PMID 24880136, PMID 25338927, PMID 25579873, PMID 25624403, PMID 25664595, PMID 25828648, PMID 26926930, PMID 27029851, PMID 27576310, PMID 28650869, PMID 29998882, PMID 30229398, PMID 31516734, PMID 31811953, PMID 33020898, PMID 33287583, PMID 34175001, PMID 34519832, PMID 35084335, PMID 35119530, PMID 35340032, PMID 37011138, PMID 37578800, PMID 39291052, PMID 39372414, PMID 39868569, PMID 42173654
U54RR014616 (2), 2014 (1), 2018 (1), K23GM117395 (1), R01DA037961 (1), R01HL065082 (1), U01AA021893 (1)